11 Einträge gefunden

1. High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

   1. Kuzikov, Maria
   2. Woens, Jannis
   3. Zaliani, Andrea
   4. Hambach, Julia
   5. Eden, Thomas
   6. Fehse, Boris
   7. Ellinger, Bernhard

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors

   1. Hambach, Julia
   2. Mann, Anna Marei
   3. Bannas, Peter
   4. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

   1. Hambach, Julia
   2. Fumey, William
   3. Stähler, Tobias
   4. Gebhardt, Anna Josephine
   5. Adam, Gerhard
   6. Weisel, Katja
   7. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

   1. Pape, Luca Julius
   2. Hambach, Julia
   3. Gebhardt, Anna Josephine
   4. Rissiek, Björn
   5. Stähler, Tobias
   6. Tode, Natalie
   7. Khan, Cerusch

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein

   1. Hambach, Julia
   2. Stähler, Tobias
   3. Eden, Thomas
   4. Wendt, Dorte
   5. Tode, Natalie
   6. Haag, Friedrich
   7. Tolosa, Eva

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells

   1. Baum, Natalie
   2. Eggers, Marie
   3. Koenigsdorf, Julia
   4. Menzel, Stephan
   5. Hambach, Julia
   6. Staehler, Tobias
   7. Fliegert, Ralf

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells

   1. Baum, Natalie
   2. Fliegert, Ralf
   3. Bauche, Andreas
   4. Hambach, Julia
   5. Menzel, Stephan
   6. Haag, Friedrich
   7. Bannas, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies

   1. Schriewer, Levin
   2. Schütze, Kerstin
   3. Petry, Katharina
   4. Hambach, Julia
   5. Fumey, William
   6. Koenigsdorf, Julia
   7. Baum, Natalie

   2020 - Forschungsinformationssystem des UKE
9. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)

   1. Hambach, Julia
   2. Riecken, Kristoffer
   3. Cichutek, Sophia
   4. Schütze, Kerstin
   5. Albrecht, Birte
   6. Petry, Katharina
   7. Röckendorf, Jana Larissa

   2020 - Forschungsinformationssystem des UKE
10. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

    1. Schütze, Kerstin
    2. Petry, Katharina
    3. Hambach, Julia
    4. Schuster, Niklas
    5. Fumey, William
    6. Schriewer, Levin
    7. Rockendorf, Jana

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
11. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

    1. Bannas, Peter
    2. Hambach, Julia
    3. Koch-Nolte, Friedrich

    2017 - Forschungsinformationssystem des UKE - frei zugänglich